Clinical Trial Update: Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intrapleural bevacizumab and cisplatin for malignant pleural effusion caused by non-small cell lung cancer has completed, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion
• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Platinol (cisplatin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Malignant Pleural Effusion | Phase 3 | Status: COMPLETED | Results posted: 2015-03-25